The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company has $6.20 Billion USD in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2024-12-31 | $$5.87 B | -5.7% |
2023-12-31 | $$6.23 B | 70.23% |
2022-12-31 | $$3.66 B | -45.36% |
2021-12-31 | $$6.70 B | -28.79% |
2020-12-31 | $$9.40 B | -2.73% |
2019-12-31 | $$9.67 B | -22.62% |
2018-12-31 | $$12.50 B | -50.48% |
2017-12-31 | $$25.24 B | -15.51% |
2016-12-31 | $$29.87 B | 6.38% |
2015-12-31 | $$28.08 B | 8.94% |
2014-12-31 | $$25.77 B | 16.66% |
2013-12-31 | $$22.09 B | 15.93% |
2012-12-31 | $$19.06 B | 0.16% |
2011-12-31 | $$19.02 B | -20.53% |
2010-12-31 | $$23.94 B | 5.63% |
2009-12-31 | $$22.66 B | 11.19% |
2008-12-31 | $$20.38 B | 14.09% |
2007-12-31 | $$17.86 B | -5.77% |
2006-12-31 | $$18.96 B | -7.27% |
2005-12-31 | $$20.45 B | 3.79% |
2004-12-31 | $$19.70 B | 1.63% |
2003-12-31 | $$19.38 B | 6.03% |
2002-12-31 | $$18.28 B | 250.49% |
2001-12-31 | $$5.21 B |
Company | Net assets | differencediff. | Country |
---|---|---|---|
![]() Pfizer PFE | $90.63 B | 1,360.24% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | $17.44 B | 181.10% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $17.66 B | 184.61% | ๐ฌ๐ง UK |
![]() Gilead Sciences GILD | $19.07 B | 207.36% | ๐บ๐ธ USA |
![]() Biogen BIIB | $16.97 B | 173.54% | ๐บ๐ธ USA |
![]() AbbVie ABBV | $1.46 B | -76.45% | ๐บ๐ธ USA |
![]() Johnson & Johnson JNJ | $78.10 B | 1,158.40% | ๐บ๐ธ USA |
![]() Illumina ILMN | $2.36 B | -61.85% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $15.84 B | 155.31% | ๐บ๐ธ USA |